AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Pharmarise Holdings Corporation
  3. Financials
  4. Revenue growth (%)

Pharmarise Holdings Corporation【JP:2796】

Market cap
¥6.2B
P/E ratio
21.8x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
May 31, 202516.6+254.70%
May 31, 20244.7+470.73%
May 31, 20230.8-159.85%
May 31, 2022-1.4-153.94%
May 31, 20212.5-288.15%
May 31, 2020-1.3-73.99%
May 31, 2019-5.2-270.16%
May 31, 20183.1-66.67%
May 31, 20179.2-59.87%
May 31, 201622.8+578.57%
May 31, 20153.4-76.95%
May 31, 201414.6+15.07%
May 31, 201312.7+22.18%
May 31, 201210.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)